Gossamer BioGOSS +3.28%16 PS Ratio is 0.72 as of Jul. 03, 2026, which is 69% below its 10-year median of 2.34. GuruFocus rates GOSS with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 933 Biotechnology companies, Gossamer Bio ranks better than 94.64% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Gossamer Bio's share price is $0.1732.
Gossamer Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.24. Hence, Gossamer Bio's PS Ratio for today is 0.72.
Good Sign:
Gossamer Bio Inc stock PS Ratio (=0.72) is close to 2-year low of 0.65.
The historical rank and industry rank for Gossamer Bio's PS Ratio or its related term are showing as below:
GOSS'
s PS Ratio Range Over the Past 10 Years
Min: 0.65 Med: 2.34 Max: 19.44
Current: 0.72
During the past 10 years, Gossamer Bio's highest PS Ratio was 19.44. The lowest was 0.65. And the median was 2.34.
GOSS's PS Ratio is ranked better than 94.64% of 933
companies
in the Biotechnology industry
Industry Median: 9.64
vs GOSS: 0.72
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Gossamer Bio PS Ratio Related Terms
Gossamer Bio PS Ratio Historical Data
* Premium members only.
The historical data trend for Gossamer Bio's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Gossamer Bio's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gossamer Bio PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gossamer Bio's PS Ratio distribution charts can be found below:
* The bar in red indicates where Gossamer Bio's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Gossamer Bio's PS Ratio for today is calculated as
Gossamer Bio's Share Price of today is $0.1732. Gossamer Bio's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.24.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Gossamer Bio (GOSS) has a PS Ratio of 0.72 as of Jul. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gossamer Bio and its competitors. This is 69% below median its historical median of 2.34. Over the past decade, Gossamer Bio's PS Ratio has ranged from 0.65 to 19.44. According to the industry distribution chart, Gossamer Bio ranks #50 out of 933 companies in the Biotechnology industry, placing it in the top 5.4%.
Is Gossamer Bio's PS Ratio too high?
Gossamer Bio's current PS Ratio of 0.72 is 69% below median its 10-year median of 2.34. Over the past 10 years, this metric has ranged from a low of 0.65 to a high of 19.44. The Biotechnology industry median PS Ratio is 9.64. Gossamer Bio's value of 0.72 is 92.5% below this industry median. Based on the distribution chart, Gossamer Bio ranks #50 out of 933 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Gossamer Bio has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's PS Ratio compare to ELTX and ACET?
According to the Biotechnology industry distribution chart, Gossamer Bio ranks #50 out of 933 companies for PS Ratio. This places Gossamer Bio in the top 5% of its industry — outperforming the majority of peers. The industry median PS Ratio is 9.64. Gossamer Bio's value of 0.72 is 92.5% below this benchmark. Historically, Gossamer Bio's own PS Ratio has ranged from 0.65 to 19.44 over the past decade. While the company's 10-year median is 2.34 vs. the industry median of 9.64, Gossamer Bio has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.64, based on 933 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gossamer Bio's current PS Ratio of 0.72 is 92.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gossamer Bio and its competitors. For the Biotechnology industry, the median PS Ratio is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gossamer Bio's current PS Ratio is 0.72, which is 69% below median its own 10-year median of 2.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current PS Ratio of 0.72. The current PS Ratio is 0.72, which is 69% below median its 10-year median of 2.34 and 92.5% below the Biotechnology industry median of 9.64. Gossamer Bio's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current PS Ratio is 0.72 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
16GF Score
Get the complete analysis for GOSS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GOSS has been successfully added to your 
